These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11926966)

  • 21. [Pharmacological treatments of Parkinson's disease].
    Nomoto M; Iwata S; Kaseda S
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):111-22. PubMed ID: 11233302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of selective monoamine oxidase B inhibitors in the therapeutic strategy of Parkinson's disease in the neurology clinics of Tirgu Mures County Emergency Clinical Hospital].
    Szász JA; Constantin V; Fazakas PA; Blényesi E; Grieb LG; Balla A; Sárig M; Szegedi K; Bartha EN; Szatmári S
    Orv Hetil; 2017 Dec; 158(51):2023-2028. PubMed ID: 29250969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa strengths and weaknesses.
    Jankovic J
    Neurology; 2002 Feb; 58(4 Suppl 1):S19-32. PubMed ID: 11909982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies.
    Pahwa R
    J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dopamine agonists in Parkinson's disease therapy - 15 years of experience of the Neurological Clinics from Tîrgu Mureș. A cross-sectional study].
    Szász JA; Viorelia C; Mihály I; Biró I; Péter C; Orbán-Kis K; Szatmári S
    Ideggyogy Sz; 2019 May; 72(5-6):187-193. PubMed ID: 31241263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Bad guys' among the antiparkinsonian drugs.
    Pirtosek Z
    Psychiatr Danub; 2009 Mar; 21(1):114-8. PubMed ID: 19270634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.
    Fischer PA
    J Neural Transm Suppl; 1995; 46():381-9. PubMed ID: 8821073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levodopa-related wearing-off in Parkinson's disease: identification and management.
    Pahwa R; Lyons KE
    Curr Med Res Opin; 2009 Apr; 25(4):841-9. PubMed ID: 19228103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment of Parkinson's disease].
    Baumann CR; Waldvogel D
    Praxis (Bern 1994); 2013 Dec; 102(25):1529-35. PubMed ID: 24326048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological treatment of Parkinson's disease.
    Münchau A; Bhatia KP
    Postgrad Med J; 2000 Oct; 76(900):602-10. PubMed ID: 11009573
    [No Abstract]   [Full Text] [Related]  

  • 33. Advanced strategies for treatment of Parkinson's disease: the role of early treatment.
    Jann MW
    Am J Manag Care; 2011 Oct; 17 Suppl 12():S315-21. PubMed ID: 22087552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thirty five years of experience in the treatment of Parkinson's disease with levodopa and associations.
    Chouza C; Buzó R; Scaramelli A; Romero S; de Medina O; Aljanati R; Dieguez E; Lisanti N; Gomensoro J
    J Neural Transm Suppl; 2006; (70):427-31. PubMed ID: 17017563
    [No Abstract]   [Full Text] [Related]  

  • 35. [Update on current care guidelines. Parkinson's disease].
    Reijo M; Atula S; Heikkinen E; Jaakkola MR; Pekka J; Keränen T; Martikainen K; Pekkonen E; Sotaniemi K;
    Duodecim; 2010; 126(19):2289-90. PubMed ID: 21086687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evolution of pharmacological treatment for Parkinson's disease.
    Almeida QJ; Hyson HC
    Recent Pat CNS Drug Discov; 2008 Jan; 3(1):50-4. PubMed ID: 18221241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early pharmacologic treatment in Parkinson's disease.
    Hauser RA
    Am J Manag Care; 2010 Mar; 16 Suppl Implications():S100-7. PubMed ID: 20297870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease.
    McIntosh E; Kent S; Gray A; Clarke CE; Williams A; Jenkinson C; Ives N; Patel S; Rick C; Wheatley K; Gray R;
    Mov Disord; 2021 Sep; 36(9):2136-2143. PubMed ID: 33960511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.